New hope for rare joint tumor: drug targets tough cases
NCT ID NCT04703322
First seen Mar 05, 2026 · Last updated May 13, 2026 · Updated 9 times
Summary
This study tests a drug called pexidartinib in 9 adults in Japan who have a rare, non-cancerous joint tumor (TGCT) that causes severe problems and cannot be helped by surgery. The goal is to see if the drug can shrink the tumor and improve joint movement, while checking for side effects. Participants take the drug by mouth and are monitored closely for safety and response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TENOSYNOVIAL GIANT CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kanazawa University Hospital
Ishikawa, 920-8641, Japan
-
Kyushu University Hospital
Fukuoka, 812-8582, Japan
-
Nagoya University Hospital
Aichi, 466-8560, Japan
-
National Cancer Center Hospital
Tokyo, 104-0045, Japan
-
National Hospital Organization Osaka National Hospital
Osaka, 540-0006, Japan
-
Osaka International Cancer Institute
Osaka, 541-8567, Japan
Conditions
Explore the condition pages connected to this study.